Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

Kirsten E. Lyke(University of Maryland, Baltimore), Robert A. Seder(National Institutes of Health), Nina M. Berkowitz(National Institutes of Health), LaSonji A. Holman(National Institutes of Health), Minglin Li(Anhui Medical University), Pamela Costner(National Institutes of Health), Anusha Gunasekera(Sanaria), Natasha KC(Sanaria), Matthew B. Laurens(University of Maryland, Baltimore), Tooba Murshedkar(Sanaria), Barney S. Graham(National Institutes of Health), Laura Novik(National Institutes of Health), Adam DeZure(National Institutes of Health), Christopher V. Plowe(University of Maryland, Baltimore), Thomas L. Richie(Sanaria), Andrew S. Ishizuka(National Institutes of Health), Abraham G. Eappen(Sanaria), Lindsay S. Garver(Walter Reed Army Institute of Research), Mary E. Enama(National Institutes of Health), Barbara J. Flynn(National Institutes of Health), B. Kim Lee Sim(Sanaria), Martha Nason(National Institutes of Health), Jamie Saunders(National Institutes of Health), Ingelise J. Gordon(National Institute of Allergy and Infectious Diseases), Eric R. James(Sanaria), Kathryn L. Zephir(National Institutes of Health), Peter F. Billingsley(Sanaria), Andrea A. Berry(University of Maryland, Baltimore), R. E. Stafford(Sanaria), Julie E. Ledgerwood(Vaccine Research Institute of San Diego), Cynthia S. Hendel(National Institutes of Health), Sumana Chakravarty(Sanaria), Mario Roederer(National Institutes of Health), Tao Li(Tongji University), Floreliz Mendoza(National Institutes of Health), Adam J. Ruben(Sanaria), Stephen L. Hoffman(Sanaria), Sarah H. Plummer(National Institutes of Health), Anita Manoj(Sanaria)
Proceedings of the National Academy of Sciences
February 21, 2017
Cited by 258


Related Papers